DXC as a free ligand exists in 30 entries. Examples include: 4HB8 4HC3 3R9V

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
FormulaC24 H40 O4
Molecular Weight392.57
Isomeric SMILESC[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

Chemical Details

Formal Charge0
Atom Count68
Chiral Atom Count10
Chiral AtomsC1, C10, C11, C12, C13, C17, C19, C3, C4, C9
Bond Count71
Aromatic Bond Count0
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03619 Different stereochemistry
NameDeoxycholic Acid
DescriptionDeoxycholic acid is a a bile acid which emulsifies and solubilizes dietary fats in the intestine, and when injected subcutaneously, it disrupts cell membranes in adipocytes and destroys fat cells in that tissue. In April 2015, deoxycholic acid was approved by the FDA for the treatment submental fat to improve aesthetic appearance and reduce facial fullness or convexity. It is marketed under the brand name Kybella by Kythera Biopharma and is the first pharmacological agent available for submental fat reduction, allowing for a safer and less invasive alternative than surgical procedures.
  • (3α,5β,12α)-3,12-dihydroxycholan-24-oic acid
  • 3alpha,12alpha-Dihydroxy-5beta-cholanic acid
  • 7α-deoxycholic acid
  • deoxycholate
  • desoxycholic acid
Brand Names
  • Belkyra
  • Kybella
Affected OrganismHumans and other mammals
IndicationFor improvement in appearance of moderate to severe fullness associated with submental fat in adults.
Mechanism of actionAs a bile acid, deoxycholic acid emulsifies fat in the gut. Synthetically derived deoxycholic acid, when injected, stimulates a targeted breakdown of adipose cells by disrupting the cell membrane and causing adipocytolysis. This results in an inflammatory reaction and clearing of the adipose tissue remnants by macrophages. Deoxycholic acid's actions are reduced by albumin and tissue-associated proteins, therefore its effect is limited to protein-poor subcutaneous fat tissue. Protein-rich tissues like muscle and skin are unaffected by deoxycholic acid, contributing to its safety profile.
Route of administrationSubcutaneous
  • Bile Acids and Salts
  • Chemical Actions and Uses
  • Cholagogues and Choleretics
  • Cholanes
  • Cholic Acids
CAS number83-44-3
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682